Indication
Cerebral thromboembolism prevention in patient at high risk of gastric ulcer
Cerebral thromboembolism prevention in a patient at high risk of gastric ulcer refers to the prophylactic management of individuals requiring antiplatelet therapy for vascular protection who simultaneously face an elevated vulnerability to mucosal injury and gastrointestinal bleeding. Read more about Cerebral thromboembolism prevention in patient at high risk of gastric ulcer
4 drugs 3 manufacturers
Drugs that treat it
Common Cerebral thromboembolism prevention in patient at high risk of gastric ulcer therapies.
ASPIRIN-OMEPRAZOLE (aspirin/omeprazole)
YOSPRALA (aspirin/omeprazole)
YOSPRALA (aspirin/omeprazole)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCerebral thromboembolism prevention in a patient at high risk of gastric ulcer refers to the prophylactic management of individuals requiring antiplatelet therapy for vascular protection who simultaneously face an elevated vulnerability to mucosal injury and gastrointestinal bleeding.
In this population, vulnerable cerebral vasculature is threatened by arterial thrombosis or cardiogenic emboli that can occlude intracranial vessels, precipitating ischemic stroke or transient ischemic attacks.
Concurrently, underlying gastrointestinal risk factors—such as advanced age, concurrent ulcerogenic medications, or a prior peptic ulcer—compromise the protective gastric epithelial barrier, leaving the stomach mucosa susceptible to acid-induced erosion and hemorrhage exacerbated by antithrombotic therapy.
This clinical state represents a delicate therapeutic balance between mitigating neurovascular ischemic damage and preventing severe upper gastrointestinal ulceration.
- healio.com
Cerebral thromboembolism prevention in a patient at high risk of gastric ulcer refers to the prophylactic management of individuals requiring antiplatelet therapy for vascular protection who simultaneously face an elevated vulnerability to mucosal injury and gastrointestinal bleeding
- nih.gov
Cerebral thromboembolism prevention in a patient at high risk of gastric ulcer refers to the prophylactic management of individuals requiring antiplatelet therapy for vascular protection who simultaneously face an elevated vulnerability to mucosal injury and gastrointestinal bleeding In this population, vulnerable cerebral vasculature is threatened by arterial thrombosis or cardiogenic emboli that can occlude intracranial vessels, precipitating ischemic stroke or transient ischemic attacks This ...
- medcentral.com
In this population, vulnerable cerebral vasculature is threatened by arterial thrombosis or cardiogenic emboli that can occlude intracranial vessels, precipitating ischemic stroke or transient ischemic attacks Concurrently, underlying gastrointestinal risk factors—such as advanced age, concurrent ulcerogenic medications, or a prior peptic ulcer—compromise the protective gastric epithelial barrier, leaving the stomach mucosa susceptible to acid-induced erosion and hemorrhage exacerbated by antith...
- ovid.com
Concurrently, underlying gastrointestinal risk factors—such as advanced age, concurrent ulcerogenic medications, or a prior peptic ulcer—compromise the protective gastric epithelial barrier, leaving the stomach mucosa susceptible to acid-induced erosion and hemorrhage exacerbated by antithrombotic therapy
Personalize your experience
Follow Cerebral thromboembolism prevention in patient at high risk of gastric ulcer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.